“Once we’ve shown that this can safely be used in human 
patients with pulmonary hypertension – and we’ve got a clinical trial in progress right now – we’ll be able to conduct studies of inhaled NO delivered in ambulatory settings, including patients’ homes, to treat chronic pulmonary hypertension, right-sided heart failure and chronic obstructive pulmonary disease.”
– Warren Zapol, MD
Director, MGH Anesthesia Center for Clinical Care Research
